Literature DB >> 9360175

Reproducibility of stress echocardiography using intravenous injection of ultrasound contrast agent (BY 963).

R Leischik1, C Kuhlmann, C Bruch, A Jeremias, T Buck, R Erbel.   

Abstract

UNLABELLED: Despite the widespread use of stress echocardiography, its reproducibility is still limited by high interobserver variability. Therefore, the purpose of the present study was to improve the reproducibility of a stress (exercise) echocardiography using a new transpulmonary ultrasound agent (BY 963). Stress echocardiography was performed in 12 healthy volunteers with suboptimal endocardial border delineation during exercise echocardiography. A special 45 degrees lateral tilted bike stress echocardiography table was used for exercise testing. Echocardiographic images were recorded on-line at rest and during exercise on a video tape and additionally digitized on-line on a stress echo computer. End-diastolic (EDVml), end-systolic (ESVml) volume and ejection fraction (EF%) were estimated in the 4-chamber view. The measurements were performed before and after injection of 2.5 ml and 5 ml BY963 at rest and in maximal exercise. A new contrast agent (BY 963) leads to a sufficient contrast effect for the left ventricular cavity after intravenous administration and permits a good delineation of left the endocardial border. The interobserver variability was determined using blinded investigation by two observers. The correlation of EDV and ESV determination at rest was r = 0.68/0.33, after 2.5 ml BY 963 r = 0.97/0.93 and after 5 ml BY 963 r = 0.90/0.93. The correlation for EDV and ESV during exercise was r = 0.52/0.33, after 2.5 ml BY 963 r = 0.88/0.80 and after 5 ml BY 963 r = 0.95/0.92. At rest mean EF without contrast was 61 +/- 6%/67 +/- 7% (r = 0. 130), after 2.5 ml BY 963 i.v. 69 +/- 8%/72 +/- 7% (r = 0.82) and after 5 ml BY 963 i.v. 73 +/- 8%/73 +/- 8% (r = 0.98%) respectively. In exercise, mean EF without contrast was 68 +/- 8%/70 +/- 6 (r = 0.013), after 2.5 ml BY 963 83 +/- 6%/81 +/- 5 and after 5 ml 83 +/- 4%/82 +/- 3 (r = 0.86).
SUMMARY: The estimation of the end-systolic volume in exercise will be improved significantly and the estimated EF values will be higher compared to EF values obtained without contrast application. Transpulmonary contrast echocardiography for analysis of left ventricular volumes and ejection fraction can be routinely used in stress echocardiography. Intravenous administration of BY 963 improves the reproducibility of quantitative analysis of left ventricular function in healthy volunteers. Further studies in patients with cardiac diseases are required to corroborate this observation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9360175     DOI: 10.1023/a:1005822920962

Source DB:  PubMed          Journal:  Int J Card Imaging        ISSN: 0167-9899


  17 in total

1.  Clinical experience with Albunex: a standard echocontrast agent for intravenous and intracoronary use.

Authors:  F J Cate; J H Cornel; P Widimsky; W Vletter; P Serruys; A Waaler
Journal:  Am J Card Imaging       Date:  1991-09

2.  Comparison of a new intravenous echo contrast agent (BY 963) with Albunex for opacification of left ventricular cavity.

Authors:  R Leischik; K D Beller; R Erbel
Journal:  Basic Res Cardiol       Date:  1996 Jan-Feb       Impact factor: 17.165

3.  Safety and efficacy of a new transpulmonary ultrasound contrast agent: initial multicenter clinical results.

Authors:  S B Feinstein; J Cheirif; F J Ten Cate; P R Silverman; P A Heidenreich; C Dick; R M Desir; W F Armstrong; M A Quinones; P M Shah
Journal:  J Am Coll Cardiol       Date:  1990-08       Impact factor: 24.094

4.  Ultrasound cardiography: contrast studies in anatomy and function.

Authors:  R Gramiak; P M Shah; D H Kramer
Journal:  Radiology       Date:  1969-04       Impact factor: 11.105

5.  [Echocontrast ventriculography. Determination of left ventricular functional parameters with special reference to digital subtraction echocardiography].

Authors:  E Grube; M Lampen; H Becher
Journal:  Z Kardiol       Date:  1986-11

6.  Exercise echocardiography for the evaluation of patients after nonsurgical coronary artery revascularization.

Authors:  H Mertes; R Erbel; U Nixdorff; S Mohr-Kahaly; S Krüger; J Meyer
Journal:  J Am Coll Cardiol       Date:  1993-04       Impact factor: 24.094

7.  Improvement of endocardial border delineation in suboptimal stress-echocardiograms using the new left heart contrast agent SH U 508 A.

Authors:  K Schröder; R Agrawal; H Völler; R Schlief; R Schröder
Journal:  Int J Card Imaging       Date:  1994-03

8.  Sonicated serum albumin in contrast echocardiography: improved segmental wall motion depiction and implications for stress echocardiography.

Authors:  L J Crouse
Journal:  Am J Cardiol       Date:  1992-06-18       Impact factor: 2.778

9.  [Stress echocardiography--a new test for evaluating the anti-ischemic effect of medication].

Authors:  R Leischik; O Adamczewski; S Pötter; R Erbel; B Lösse
Journal:  Z Kardiol       Date:  1995-08

10.  Intravenous albunex during dobutamine stress echocardiography: enhanced localization of left ventricular endocardial borders.

Authors:  R A Falcone; P A Marcovitz; J E Perez; H C Dittrich; W E Hopkins; W F Armstrong
Journal:  Am Heart J       Date:  1995-08       Impact factor: 4.749

View more
  6 in total

1.  Comparison of methods of fractional area change for detection of regional left ventricular dysfunction.

Authors:  S Carstensen; U Hoest; L Kjoeller-Hansen; K Saunamäki; D Atar; H Kelbaek
Journal:  Int J Card Imaging       Date:  2000-08

2.  Non-contrast second harmonic imaging improves interobserver agreement and accuracy of dobutamine stress echocardiography in patients with impaired image quality.

Authors:  A Franke; R Hoffmann; H P Kühl; W Lepper; O A Breithardt; M Schormann; P Hanrath
Journal:  Heart       Date:  2000-02       Impact factor: 5.994

Review 3.  New ultrasound contrast agents for left ventricular and myocardial opacification.

Authors:  J D Kasprzak; F J Ten Cate
Journal:  Herz       Date:  1998-12       Impact factor: 1.443

Review 4.  Echocardiographic assessment of myocardial ischemia.

Authors:  Roman Leischik; Birgit Dworrak; Fabian Sanchis-Gomar; Alejandro Lucia; Thomas Buck; Raimund Erbel
Journal:  Ann Transl Med       Date:  2016-07

5.  Intraobserver and interobserver reproducibility for radial, circumferential and longitudinal strain echocardiography.

Authors:  R Leischik; B Dworrak; K Hensel
Journal:  Open Cardiovasc Med J       Date:  2014-10-17

Review 6.  The Utility of Cardiac Reserve for the Early Detection of Cancer Treatment-Related Cardiac Dysfunction: A Comprehensive Overview.

Authors:  Stephen Foulkes; Guido Claessen; Erin J Howden; Robin M Daly; Steve F Fraser; Andre La Gerche
Journal:  Front Cardiovasc Med       Date:  2020-03-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.